237 related articles for article (PubMed ID: 27930339)
1. Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling.
Gan J; Ke X; Jiang J; Dong H; Yao Z; Lin Y; Lin W; Wu X; Yan S; Zhuang Y; Chu WK; Cai R; Zhang X; Cheung HS; Block NL; Pang CP; Schally AV; Zhang H
Proc Natl Acad Sci U S A; 2016 Dec; 113(51):14745-14750. PubMed ID: 27930339
[TBL] [Abstract][Full Text] [Related]
2. Signaling mechanisms of growth hormone-releasing hormone receptor in LPS-induced acute ocular inflammation.
Liang WC; Ren JL; Yu QX; Li J; Ng TK; Chu WK; Qin YJ; Chu KO; Schally AV; Pang CP; Chan SO
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6067-6074. PubMed ID: 32123064
[TBL] [Abstract][Full Text] [Related]
3. Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Schally AV; Wang H; He J; Cai R; Sha W; Popovics P; Perez R; Vidaurre I; Zhang X
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):12028-12033. PubMed ID: 30373845
[TBL] [Abstract][Full Text] [Related]
4. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
Jimenez JJ; DelCanto GM; Popovics P; Perez A; Vila Granda A; Vidaurre I; Cai RZ; Rick FG; Swords RT; Schally AV
Br J Haematol; 2018 May; 181(4):476-485. PubMed ID: 29663325
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of experimental small-cell and non-small-cell lung cancers by novel antagonists of growth hormone-releasing hormone.
Wang H; Zhang X; Vidaurre I; Cai R; Sha W; Schally AV
Int J Cancer; 2018 Jun; 142(11):2394-2404. PubMed ID: 29435973
[TBL] [Abstract][Full Text] [Related]
6. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
Schally AV; Varga JL; Engel JB
Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
[TBL] [Abstract][Full Text] [Related]
7. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function.
Szalontay L; Schally AV; Popovics P; Vidaurre I; Krishan A; Zarandi M; Cai RZ; Klukovits A; Block NL; Rick FG
Cell Cycle; 2014; 13(17):2790-7. PubMed ID: 25486366
[TBL] [Abstract][Full Text] [Related]
8. Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells.
Chu WK; Law KS; Chan SO; Yam JC; Chen LJ; Zhang H; Cheung HS; Block NL; Schally AV; Pang CP
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14396-14401. PubMed ID: 27911838
[TBL] [Abstract][Full Text] [Related]
9. Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia.
Rick FG; Schally AV; Block NL; Nadji M; Szepeshazi K; Zarandi M; Vidaurre I; Perez R; Halmos G; Szalontay L
Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3755-60. PubMed ID: 21321192
[TBL] [Abstract][Full Text] [Related]
10. Combination of GHRH antagonists and docetaxel shows experimental effectiveness for the treatment of triple-negative breast cancers.
Seitz S; Rick FG; Schally AV; Treszl A; Hohla F; Szalontay L; Zarandi M; Ortmann O; Engel JB; Buchholz S
Oncol Rep; 2013 Jul; 30(1):413-8. PubMed ID: 23624870
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
Muñoz-Moreno L; Arenas MI; Schally AV; Fernández-Martínez AB; Zarka E; González-Santander M; Carmena MJ; Vacas E; Prieto JC; Bajo AM
Int J Cancer; 2013 Feb; 132(4):755-65. PubMed ID: 22777643
[TBL] [Abstract][Full Text] [Related]
12. Antagonists of growth hormone-releasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers.
Perez R; Schally AV; Vidaurre I; Rincon R; Block NL; Rick FG
Oncotarget; 2012 Sep; 3(9):988-97. PubMed ID: 22941871
[TBL] [Abstract][Full Text] [Related]
13. Splice variant of growth hormone-releasing hormone receptor drives esophageal squamous cell carcinoma conferring a therapeutic target.
Xiong X; Ke X; Wang L; Yao Z; Guo Y; Zhang X; Chen Y; Pang CP; Schally AV; Zhang H
Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6726-6732. PubMed ID: 32156725
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
Heinrich E; Schally AV; Buchholz S; Rick FG; Halmos G; Mile M; Groot K; Hohla F; Zarandi M; Varga JL
Prostate; 2008 Dec; 68(16):1763-72. PubMed ID: 18729085
[TBL] [Abstract][Full Text] [Related]
15. Induction of Apoptosis in Pterygium Cells by Antagonists of Growth Hormone-Releasing Hormone Receptors.
Qin YJ; Chu WK; Huang L; Ng CHY; Chan TCY; Cao D; Yang C; Zhang L; Huang SP; Li J; Lin HL; Li WQ; Chen L; Schally AV; Chan SO; Zhang HY; Pang CP
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5060-5066. PubMed ID: 30357400
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancer.
Muñoz-Moreno L; Schally AV; Prieto JC; Carmena MJ; Bajo AM
Prostate; 2018 Sep; 78(12):915-926. PubMed ID: 29748961
[TBL] [Abstract][Full Text] [Related]
17. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
[TBL] [Abstract][Full Text] [Related]
18. Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation.
Qin YJ; Chan SO; Chong KK; Li BF; Ng TK; Yip YW; Chen H; Zhang M; Block NL; Cheung HS; Schally AV; Pang CP
Proc Natl Acad Sci U S A; 2014 Dec; 111(51):18303-8. PubMed ID: 25489106
[TBL] [Abstract][Full Text] [Related]
19. The effect of GHRH antagonists on human glioblastomas and their mechanism of action.
Pozsgai E; Schally AV; Zarandi M; Varga JL; Vidaurre I; Bellyei S
Int J Cancer; 2010 Nov; 127(10):2313-22. PubMed ID: 20162575
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
